Showing 1 - 20 results of 67 for search 'IS Yavelov', query time: 1.15s Refine Results
  1. 1
    Disputable issues of anticoagulant therapy: exacerbation of coronary heart disease and transcutaneous interventions in patients with cardiac fibrillation treated with vitamin K antagonists

    Disputable issues of anticoagulant therapy: exacerbation of coronary heart disease and transcutaneous interventions in patients with cardiac fibrillation treated with vitamin K ant... by I S Yavelov, I S Yavelov

    Published 2009-09-01
    Get full text
    Article
  2. 2
    Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation

    Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation by IS Yavelov

    Published 2014-12-01
    Get full text
    Article
  3. 3
    Parenteral anticoagulants in the treatment of acute coronary syndrome: what modern clinical guidelines say

    Parenteral anticoagulants in the treatment of acute coronary syndrome: what modern clinical guidelines say by I. S. Yavelov

    Published 2022-06-01
    Get full text
    Article
  4. 4
    Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial

    Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial by I. S. Yavelov

    Published 2022-02-01
    Get full text
    Article
  5. 5
    Elderly patient with atrial fibrillation and coronary risks

    Elderly patient with atrial fibrillation and coronary risks by I. S. Yavelov

    Published 2021-07-01
    Get full text
    Article
  6. 6
    DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER

    DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER by I. S. Yavelov

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Main indications for peroral anticoagulants: how to choose an optimal drug

    Main indications for peroral anticoagulants: how to choose an optimal drug by I. S. Yavelov

    Published 2018-05-01
    Get full text
    Article
  8. 8
    CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN

    CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN by I. S. Yavelov

    Published 2015-12-01
    Get full text
    Article
  9. 9
    CONTINUOUS ECG MONITORING: WHAT DO CLINICAL GUIDELINES SAY

    CONTINUOUS ECG MONITORING: WHAT DO CLINICAL GUIDELINES SAY by I. S. Yavelov

    Published 2017-12-01
    Get full text
    Article
  10. 10
    Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account?

    Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account? by I. S. Yavelov

    Published 2023-01-01
    Get full text
    Article
  11. 11
    RANDOMIZED CLINICAL TRIALS AND REVIEW OF EVERYDAY CLINICAL PRACTICE: WHAT IT MEANS FOR THE CLINICIAN. LECTURE

    RANDOMIZED CLINICAL TRIALS AND REVIEW OF EVERYDAY CLINICAL PRACTICE: WHAT IT MEANS FOR THE CLINICIAN. LECTURE by I. S. Yavelov

    Published 2018-05-01
    Get full text
    Article
  12. 12
    PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW

    PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW by I. S. Yavelov

    Published 2017-09-01
    Get full text
    Article
  13. 13
    Increased level of cardiac troponin I determined by a highly sensitive method: clinical significance beyond the assessment of the severity and prognosis of acute and chronic diseases

    Increased level of cardiac troponin I determined by a highly sensitive method: clinical significance beyond the assessment of the severity and prognosis of acute and chronic diseas... by I. S. Yavelov

    Published 2021-09-01
    Get full text
    Article
  14. 14
    Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021

    Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 by I. S. Yavelov

    Published 2022-01-01
    Get full text
    Article
  15. 15
    Low-molecular heparins in thrombolytic therapy of myocardial infarction patients

    Low-molecular heparins in thrombolytic therapy of myocardial infarction patients by I. S. Yavelov

    Published 2009-12-01
    Get full text
    Article
  16. 16
    Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?

    Enoxaparin in cardiovascular disease: how to improve effectiveness and safety? by I. S. Yavelov

    Published 2011-12-01
    Get full text
    Article
  17. 17
    ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE

    ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE by I. S. Yavelov

    Published 2009-03-01
    Get full text
    Article
  18. 18
    Prevention of cardiovascular events in patients with stable coronary artery disease: myocardial revascularization or pharmacological treatment?

    Prevention of cardiovascular events in patients with stable coronary artery disease: myocardial revascularization or pharmacological treatment? by I. S. Yavelov

    Published 2021-05-01
    Get full text
    Article
  19. 19
    STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION. WHAT ROCKET AF STUDY RESULTS SAY

    STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION. WHAT ROCKET AF STUDY RESULTS SAY by I. S. Yavelov

    Published 2017-11-01
    Get full text
    Article
  20. 20
    Regarding the choice of Р2У<sub>12</sub> platelet receptor blocker in the early invasive approach to acute coronary syndrome treatment in patients without indications for long-term anticoagulant use

    Regarding the choice of Р2У<sub>12</sub> platelet receptor blocker in the early invasive approach to acute coronary syndrome treatment in patients without indications for long-term... by I. S. Yavelov

    Published 2020-12-01
    Get full text
    Article

Search Tools: